Mohammad Karimian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohammad Karimian has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Hossein Nikzad
Anatomical Sciences Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
9 shared publications Mohaddeseh Behjati
Cellular, Molecular and Genetics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
5 shared publications- Abolfazl Azami Tameh
Anatomical Sciences Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
4 shared publications Hossein Nikzad
Anatomical Sciences Research Center, Kashan University of Medical Sciences, Kashan, Iran
4 shared publications- Mohaddeseh Behjati
Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
4 shared publications Narges Mobasseri
Gametogenesis Research Center, Kashan University of Medical Sciences, Kashan, Iran
4 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by The Korean Society for Reproductive Medicine in Clinical and Experimental Reproductive Medicine
Long non-coding RNAs in female infertility: Advancing from molecular insights to clinical relevance
A broad range of genetic and epigenetic factors contributes to female infertility, a substantial proportion of which is related to ovulatory disorders. Any factor that disrupts the normal function of key ovarian components, including the follicle, the enclosed oocyte, and surrounding somatic cells, may contribute to female infertility. Investigating the molecular factors involved in folliculogenesis and reproductive pathways may substantially improve the treatment of diseases affecting the female reproductive system. Long non-coding RNAs (lncRNAs), as key regulators of molecular and biological processes, play important roles in ovarian function and female fertility. These effects are mediated through interactions with DNA, RNA, and proteins, and lncRNAs are involved in processes such as granulosa cell differentiation, follicular growth, and ovarian hormonal regulation. Altered lncRNA expression may contribute to reproductive disorders such as polycystic ovary syndrome, endometriosis, and primary ovarian insufficiency. In addition, several lncRNAs have been proposed as potential biomarkers for the diagnosis of female reproductive disorders and as novel therapeutic targets. However, many functional mechanisms of these molecules remain unclear. This review summarizes recent scientific findings on the role of lncRNAs in the pathophysiology of female infertility and evaluates their potential for the development of novel diagnostic and therapeutic approaches. A better understanding of these molecular pathways may support more effective strategies for managing and treating female infertility.
- 31 August 2026
- Published by The Korean Society for Reproductive Medicine in Clinical and Experimental Reproductive Medicine
Open AccessLong non-coding RNAs in female infertility: Advancing from molecular insights to clinical relevance
A broad range of genetic and epigenetic factors contributes to female infertility, a substantial proportion of which is related to ovulatory disorders. Any factor that disrupts the normal function of key ovarian components, including the follicle, the enclosed oocyte, and surrounding somatic cells, may contribute to female infertility. Investigating the molecular factors involved in folliculogenesis and reproductive pathways may substantially improve the treatment of diseases affecting the female reproductive system. Long non-coding RNAs (lncRNAs), as key regulators of molecular and biological processes, play important roles in ovarian function and female fertility. These effects are mediated through interactions with DNA, RNA, and proteins, and lncRNAs are involved in processes such as granulosa cell differentiation, follicular growth, and ovarian hormonal regulation. Altered lncRNA expression may contribute to reproductive disorders such as polycystic ovary syndrome, endometriosis, and primary ovarian insufficiency. In addition, several lncRNAs have been proposed as potential biomarkers for the diagnosis of female reproductive disorders and as novel therapeutic targets. However, many functional mechanisms of these molecules remain unclear. This review summarizes recent scientific findings on the role of lncRNAs in the pathophysiology of female infertility and evaluates their potential for the development of novel diagnostic and therapeutic approaches. A better understanding of these molecular pathways may support more effective strategies for managing and treating female infertility.
- Open Access
- 15 July 2026
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 143, 105991
Regulatory role of noncoding RNAs in infections caused by Rhabdoviridae family viruses
- 15 July 2026
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 143, 105991
Open AccessRegulatory role of noncoding RNAs in infections caused by Rhabdoviridae family viruses
- 4 July 2026
- Published by Maad Rayan Publishing Company in Pharmaceutical Sciences
- Vol. 32 (4) , 544-555
Antioxidant-Rich Vitex agnus-castus Fruit Extract Attenuates Toluene-Induced Hepatic Apoptosis and Autophagy Dysregulation
Introduction: Toluene can trigger oxidative stress, cellular injury, and dysregulation of apoptosis and autophagy pathways in the liver. Vitex agnus-castus (VAC) fruit extract, known for its rich antioxidant, flavonoid, and phenolic contents, may counteract these effects through its free radical-scavenging and cytoprotective actions. This study aimed to evaluate the protective role of VAC fruit extract on key apoptotic and autophagy-related marker genes in toluene-exposed mice, supported by bioinformatics analysis. Methods: Flavonoid and phenolic contents of VAC fruit extract were measured colorimetrically, and antioxidant activity was assessed using the 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assay. Adult male mice received toluene (100 mg/kg), VAC fruit extract (100 or 200 mg/kg), or their combination. The evaluation included gene expression analysis by quantitative real-time polymerase chain reaction (qRT-PCR), measurement of serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and molecular docking analysis along with gene network construction using bioinformatics tools. Results: The flavonoid, total phenolic content, and antioxidant potential of the VAC fruit extract were 60.24, 126.35, and 455.23 mg equivalents per gram of extract, respectively, indicating its high antioxidant capacity. Toluene upregulated Bax (P<0.01), Lc3 (P<0.05), and Beclin1 (P<0.05) gene expression, which was significantly downregulated by VAC (100 or 200 mg/kg; P<0.05 to P<0.01), while Bcl2 gene expression, as well as AST and ALT levels, remained unchanged. Molecular docking confirmed the strong binding of VAC compounds to the target proteins, which may contribute to their functional alterations. Conclusion: The strong antioxidant and bioactive features of VAC fruit extract contributed to the modulation of oxidative stress-induced apoptotic and autophagy gene expression in the liver of toluene-exposed mice, highlighting its potential as a hepatoprotective and regulatory compound against toluene-induced toxicity.
- 4 July 2026
- Published by Maad Rayan Publishing Company in Pharmaceutical Sciences
- Vol. 32 (4) , 544-555
Antioxidant-Rich Vitex agnus-castus Fruit Extract Attenuates Toluene-Induced Hepatic Apoptosis and Autophagy Dysregulation
Introduction: Toluene can trigger oxidative stress, cellular injury, and dysregulation of apoptosis and autophagy pathways in the liver. Vitex agnus-castus (VAC) fruit extract, known for its rich antioxidant, flavonoid, and phenolic contents, may counteract these effects through its free radical-scavenging and cytoprotective actions. This study aimed to evaluate the protective role of VAC fruit extract on key apoptotic and autophagy-related marker genes in toluene-exposed mice, supported by bioinformatics analysis. Methods: Flavonoid and phenolic contents of VAC fruit extract were measured colorimetrically, and antioxidant activity was assessed using the 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assay. Adult male mice received toluene (100 mg/kg), VAC fruit extract (100 or 200 mg/kg), or their combination. The evaluation included gene expression analysis by quantitative real-time polymerase chain reaction (qRT-PCR), measurement of serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and molecular docking analysis along with gene network construction using bioinformatics tools. Results: The flavonoid, total phenolic content, and antioxidant potential of the VAC fruit extract were 60.24, 126.35, and 455.23 mg equivalents per gram of extract, respectively, indicating its high antioxidant capacity. Toluene upregulated Bax (P<0.01), Lc3 (P<0.05), and Beclin1 (P<0.05) gene expression, which was significantly downregulated by VAC (100 or 200 mg/kg; P<0.05 to P<0.01), while Bcl2 gene expression, as well as AST and ALT levels, remained unchanged. Molecular docking confirmed the strong binding of VAC compounds to the target proteins, which may contribute to their functional alterations. Conclusion: The strong antioxidant and bioactive features of VAC fruit extract contributed to the modulation of oxidative stress-induced apoptotic and autophagy gene expression in the liver of toluene-exposed mice, highlighting its potential as a hepatoprotective and regulatory compound against toluene-induced toxicity.
- Top Cited PapersOpen Access
- 19 February 2026
- Published by Elsevier in Toxicology Reports
- Vol. 16, 102226
Microplastics and male reproductive system: A comprehensive review based on cellular and molecular effects
- 19 February 2026
- Published by Elsevier in Toxicology Reports
- Vol. 16, 102226
Top Cited PapersOpen AccessMicroplastics and male reproductive system: A comprehensive review based on cellular and molecular effects
- Open Access
- 1 December 2025
- Published by Global Sciences in Cellular, Molecular and Biomedical Reports
- Vol. 5 (4) , 304-322
Ethnic-specific association of LEPR rs1137101 polymorphism with polycystic ovary syndrome risk: A meta-analysis and bioinformatics study
Polycystic ovary syndrome is a common endocrine disorder with complex genetic and metabolic factors. Polymorphisms in the leptin receptor gene may alter the risk of polycystic ovary syndrome. One of the key polymorphisms in the leptin receptor gene is rs1137101, and this study aimed to investigate the relationship between this polymorphism and the risk of polycystic ovary syndrome using a meta-analysis approach, followed by a bioinformatics assessment. In a systematic search, reliable databases such as PubMed, Scopus, Google Scholar, and ScienceDirect were assessed. The association strength of rs1137101 polymorphism with polycystic ovary syndrome risk was estimated by odds ratio and 95% confidence interval. Some bioinformatics tools were used to evaluate the effect of rs1137101 polymorphism on the leptin receptor gene function. After a systematic search, eight eligible studies were included in our meta-analysis. Our analysis showed that this polymorphism was associated with an increased risk of polycystic ovary syndrome in the Asian (AA vs. AG+GG: OR= 2.6075, 95%CI= 1.6260-4.1816, P<0.001; AA vs. AG: OR= 2.0787, 95%CI= 1.2784; 3.3799, P= 0.003) and Caucasian (AA vs. AG: OR=1.5041, 95%CI=1.0334-2.1891, P=0.033) populations. Meanwhile, a different result was obtained in the Arab population and the polymorphism of rs1137101 was found to be inversely associated with the risk of polycystic ovary syndrome (AA vs. AG: OR=0.7351, 95%CI=0.5833-0.9265, P=0.009). The bioinformatics analysis also showed that this polymorphism could affect certain features and interactions of the leptin receptor protein. Based on the obtained results, rs1137101 polymorphism can affect the risk of polycystic ovary syndrome with a race-dependent approach.
- 1 December 2025
- Published by Global Sciences in Cellular, Molecular and Biomedical Reports
- Vol. 5 (4) , 304-322
Open AccessEthnic-specific association of LEPR rs1137101 polymorphism with polycystic ovary syndrome risk: A meta-analysis and bioinformatics study
Polycystic ovary syndrome is a common endocrine disorder with complex genetic and metabolic factors. Polymorphisms in the leptin receptor gene may alter the risk of polycystic ovary syndrome. One of the key polymorphisms in the leptin receptor gene is rs1137101, and this study aimed to investigate the relationship between this polymorphism and the risk of polycystic ovary syndrome using a meta-analysis approach, followed by a bioinformatics assessment. In a systematic search, reliable databases such as PubMed, Scopus, Google Scholar, and ScienceDirect were assessed. The association strength of rs1137101 polymorphism with polycystic ovary syndrome risk was estimated by odds ratio and 95% confidence interval. Some bioinformatics tools were used to evaluate the effect of rs1137101 polymorphism on the leptin receptor gene function. After a systematic search, eight eligible studies were included in our meta-analysis. Our analysis showed that this polymorphism was associated with an increased risk of polycystic ovary syndrome in the Asian (AA vs. AG+GG: OR= 2.6075, 95%CI= 1.6260-4.1816, P<0.001; AA vs. AG: OR= 2.0787, 95%CI= 1.2784; 3.3799, P= 0.003) and Caucasian (AA vs. AG: OR=1.5041, 95%CI=1.0334-2.1891, P=0.033) populations. Meanwhile, a different result was obtained in the Arab population and the polymorphism of rs1137101 was found to be inversely associated with the risk of polycystic ovary syndrome (AA vs. AG: OR=0.7351, 95%CI=0.5833-0.9265, P=0.009). The bioinformatics analysis also showed that this polymorphism could affect certain features and interactions of the leptin receptor protein. Based on the obtained results, rs1137101 polymorphism can affect the risk of polycystic ovary syndrome with a race-dependent approach.
- 30 June 2025
- Vol. 80 (3) , 591-604
COVID-19 and ACE2 Receptor in Different Tissues: From Pathophysiologic Function To Therapeutic Responses
SARS-CoV-2, the virus responsible for COVID-19, is characterized by its high transmission rate, leading to a global pandemic. Millions of people have lost their lives due to the infection caused by this virus. The ability of the virus to spread rapidly and infect large numbers of people has highlighted the need to understand its mechanisms of infection. Angiotensin-converting enzyme 2 (ACE2) is an essential receptor for SARS-CoV-2 cell entry. SARS-CoV-2 exhibits a high affinity to this receptor and shows high infectivity, leading to an explosive increase in patients infected with COVID-19. ACE2 is the carboxypeptidase homolog of ACE, which produces angiotensin II, the main active peptide of the renin-angiotensin system. From a pathophysiological perspective, this system regulates vital processes across different organs. Additionally, ACE2 enzyme activity could play a protective role against acute respiratory distress syndrome (ARDS) caused by viral pneumonia. Upon infection, SARS-CoV-2 downregulates the expression of ACE2, which is possibly related to the pathogenesis of ARDS. Since this receptor is present in various other tissues such as the heart, kidney, gastrointestinal tract, reproductive system, and sensory organs, it may contribute to pathological symptoms in these organs. Thus, ACE2 is not only a receptor for SARS-CoV-2 but may also play a crucial role in various aspects of the pathogenesis of COVID-19 and potential post-COVID-19 syndromes. Administering ACE2 could competitively bind to SARS-CoV, thereby reducing viral spike protein from attaching to transmembrane ACE2 and consequently reducing viral cell entry into cells and COVID-19 symptoms. In this review, we first examine the role of ACE2 in the pathophysiology of SARS-CoV-2 across different tissues and propose treatment strategies for COVID-19 that involve ACE2.
- 30 June 2025
- Vol. 80 (3) , 591-604
COVID-19 and ACE2 Receptor in Different Tissues: From Pathophysiologic Function To Therapeutic Responses
SARS-CoV-2, the virus responsible for COVID-19, is characterized by its high transmission rate, leading to a global pandemic. Millions of people have lost their lives due to the infection caused by this virus. The ability of the virus to spread rapidly and infect large numbers of people has highlighted the need to understand its mechanisms of infection. Angiotensin-converting enzyme 2 (ACE2) is an essential receptor for SARS-CoV-2 cell entry. SARS-CoV-2 exhibits a high affinity to this receptor and shows high infectivity, leading to an explosive increase in patients infected with COVID-19. ACE2 is the carboxypeptidase homolog of ACE, which produces angiotensin II, the main active peptide of the renin-angiotensin system. From a pathophysiological perspective, this system regulates vital processes across different organs. Additionally, ACE2 enzyme activity could play a protective role against acute respiratory distress syndrome (ARDS) caused by viral pneumonia. Upon infection, SARS-CoV-2 downregulates the expression of ACE2, which is possibly related to the pathogenesis of ARDS. Since this receptor is present in various other tissues such as the heart, kidney, gastrointestinal tract, reproductive system, and sensory organs, it may contribute to pathological symptoms in these organs. Thus, ACE2 is not only a receptor for SARS-CoV-2 but may also play a crucial role in various aspects of the pathogenesis of COVID-19 and potential post-COVID-19 syndromes. Administering ACE2 could competitively bind to SARS-CoV, thereby reducing viral spike protein from attaching to transmembrane ACE2 and consequently reducing viral cell entry into cells and COVID-19 symptoms. In this review, we first examine the role of ACE2 in the pathophysiology of SARS-CoV-2 across different tissues and propose treatment strategies for COVID-19 that involve ACE2.
- Open Access
- 11 February 2025
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 16 (1) , 1-20
Therapeutic potential of exosomal lncRNAs derived from stem cells in wound healing: focusing on mesenchymal stem cells
The self-renewal ability and multipotency of stem cells give them great potential for use in wound healing. Stem cell-derived exosomes, owing to their close biological resemblance to their parent cells, offer a more efficient, safer, and economical approach for facilitating cellular communication and interactions within different environments. This potential makes them particularly valuable in the treatment of both acute and chronic wounds, such as lacerations, burns, and diabetic ulcers. Long non-coding RNAs (lncRNAs) enclosed in exosomes, as one of the leading actors of these extracellular microvesicles, through interaction with miRNAs and regulation of various signaling pathways involved in inflammation, angiogenesis, cell proliferation, and migration, could heal the wounds. Exosome-derived lncRNAs from stem cells facilitate extracellular matrix remodeling through interaction between macrophages and fibroblasts. Moreover, alongside regulating the expression of inflammatory cytokines, controlling reactive oxygen species levels, and enhancing autophagic activity, they also modulate immune responses to support wound healing. Regulating the expression of genes and signaling pathways related to angiogenesis, by increasing blood supply and accelerating the delivery of essential substances to the wound environment, is another effect exosomal lncRNAs derived from stem cells for wound healing. These lncRNAs can also enhance skin wound healing by regulating homeostasis, increasing the proliferation and differentiation of cells involved in the wound-healing process, and enhancing fibroblast viability and migration to the injury site. Ultimately, exosome-derived lncRNAs from stem cells offer valuable and novel insights into the molecular mechanisms underlying improved wound healing. They can pave the way for potential therapeutic strategies, fostering further research for a better future. Meanwhile, exosomes derived from mesenchymal stem cells, due to their exceptional regenerative properties, as well as the lncRNAs derived from these exosomes, have emerged as one of the innovative tools in wound healing. This review article aims to narrate the cellular and molecular roles of exosome-derived lncRNAs from stem cells in enhancing wound healing with a focus on mesenchymal stem cells.
- 11 February 2025
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 16 (1) , 1-20
Open AccessTherapeutic potential of exosomal lncRNAs derived from stem cells in wound healing: focusing on mesenchymal stem cells
The self-renewal ability and multipotency of stem cells give them great potential for use in wound healing. Stem cell-derived exosomes, owing to their close biological resemblance to their parent cells, offer a more efficient, safer, and economical approach for facilitating cellular communication and interactions within different environments. This potential makes them particularly valuable in the treatment of both acute and chronic wounds, such as lacerations, burns, and diabetic ulcers. Long non-coding RNAs (lncRNAs) enclosed in exosomes, as one of the leading actors of these extracellular microvesicles, through interaction with miRNAs and regulation of various signaling pathways involved in inflammation, angiogenesis, cell proliferation, and migration, could heal the wounds. Exosome-derived lncRNAs from stem cells facilitate extracellular matrix remodeling through interaction between macrophages and fibroblasts. Moreover, alongside regulating the expression of inflammatory cytokines, controlling reactive oxygen species levels, and enhancing autophagic activity, they also modulate immune responses to support wound healing. Regulating the expression of genes and signaling pathways related to angiogenesis, by increasing blood supply and accelerating the delivery of essential substances to the wound environment, is another effect exosomal lncRNAs derived from stem cells for wound healing. These lncRNAs can also enhance skin wound healing by regulating homeostasis, increasing the proliferation and differentiation of cells involved in the wound-healing process, and enhancing fibroblast viability and migration to the injury site. Ultimately, exosome-derived lncRNAs from stem cells offer valuable and novel insights into the molecular mechanisms underlying improved wound healing. They can pave the way for potential therapeutic strategies, fostering further research for a better future. Meanwhile, exosomes derived from mesenchymal stem cells, due to their exceptional regenerative properties, as well as the lncRNAs derived from these exosomes, have emerged as one of the innovative tools in wound healing. This review article aims to narrate the cellular and molecular roles of exosome-derived lncRNAs from stem cells in enhancing wound healing with a focus on mesenchymal stem cells.
- Top Cited PapersOpen Access
- 11 November 2024
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 22 (1) , 1-34
Concerning influences of micro/nano plastics on female reproductive health: focusing on cellular and molecular pathways from animal models to human studies
The female reproductive system can face serious disorders and show reproductive abnormalities under the influence of environmental pollutants. Microplastics (MPs) and nanoplastics (NPs) as emerging pollutants, by affecting different components of this system, may make female fertility a serious challenge. Animal studies have demonstrated that exposure to these substances weakens the function of ovaries and causes a decrease in ovarian reserve capacity. Also, continuous exposure to micro/nano plastics (MNPs) leads to increased levels of reactive oxygen species, induction of oxidative stress, inflammatory responses, apoptosis of granulosa cells, and reduction of the number of ovarian follicles. Furthermore, by interfering with the hypothalamic-pituitary-ovarian axis, these particles disturb the normal levels of ovarian androgens and endocrine balance and delay the growth of gonads. Exposure to MNPs can accelerate carcinogenesis in the female reproductive system in humans and animal models. Animal studies have determined that these particles can accumulate in the placenta, causing metabolic changes, disrupting the development of the fetus, and endangering the health of future generations. In humans, the presence of micro/nanoplastics in placenta tissue, infant feces, and breast milk has been reported. These particles can directly affect the health of the mother and fetus, increasing the risk of premature birth and other pregnancy complications. This review aims to outline the hazardous effects of micro/nano plastics on female reproductive health and fetal growth and discuss the results of animal experiments and human research focusing on cellular and molecular pathways.
- 11 November 2024
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 22 (1) , 1-34
Top Cited PapersOpen AccessConcerning influences of micro/nano plastics on female reproductive health: focusing on cellular and molecular pathways from animal models to human studies
The female reproductive system can face serious disorders and show reproductive abnormalities under the influence of environmental pollutants. Microplastics (MPs) and nanoplastics (NPs) as emerging pollutants, by affecting different components of this system, may make female fertility a serious challenge. Animal studies have demonstrated that exposure to these substances weakens the function of ovaries and causes a decrease in ovarian reserve capacity. Also, continuous exposure to micro/nano plastics (MNPs) leads to increased levels of reactive oxygen species, induction of oxidative stress, inflammatory responses, apoptosis of granulosa cells, and reduction of the number of ovarian follicles. Furthermore, by interfering with the hypothalamic-pituitary-ovarian axis, these particles disturb the normal levels of ovarian androgens and endocrine balance and delay the growth of gonads. Exposure to MNPs can accelerate carcinogenesis in the female reproductive system in humans and animal models. Animal studies have determined that these particles can accumulate in the placenta, causing metabolic changes, disrupting the development of the fetus, and endangering the health of future generations. In humans, the presence of micro/nanoplastics in placenta tissue, infant feces, and breast milk has been reported. These particles can directly affect the health of the mother and fetus, increasing the risk of premature birth and other pregnancy complications. This review aims to outline the hazardous effects of micro/nano plastics on female reproductive health and fetal growth and discuss the results of animal experiments and human research focusing on cellular and molecular pathways.
- 9 November 2024
- Published by Wiley in International Journal of Immunogenetics
- Vol. 52 (1) , 1-23
Association of PADI4 Gene Polymorphisms With Susceptibility to Rheumatoid Arthritis: Evidence From 24 Case–Control Studies
This study aims to investigate the association of rs11203366, rs11203367, rs874881, rs2240340 and rs1748033 polymorphisms of protein‐arginine deiminase type 4 (PADI4) gene with the risk of rheumatoid arthritis (RA) through a meta‐analysis that was followed with a bioinformatics approach. The data were collected from reputable articles and underwent quantitative analysis, followed by in silico analysis using some bioinformatics tools. The results showed that rs874881 polymorphism in Latino (G vs. C: OR = 1.35, 95% CI = 1.11–1.65, p = 0.003; GG + CG vs. CC: OR = 2.02, 95% CI = 1.41–2.89, p = 0.0001; CG vs. CC + GG: OR = 1.38, 95% CI = 1.04–1.83, p = 0.027; GG vs. CC: OR = 2.09, 95% CI = 1.35–3.23, p = 0.001; CG vs. CC: OR = 1.98, 95% CI = 1.36–2.87, p = 0.00033) and rs1748033 in Caucasian population (T vs. C: OR = 1.25, 95% CI = 1.07–1.45, p = 0.005; TT vs. CT + CC: OR = 1.34, 95% CI = 1.09–1.64, p = 0.005, TT + CT vs. CC: OR = 1.26, 95% CI = 1.09–1.44, p = 0.001; TT vs. CC: OR = 1.59, 95% CI = 1.13–2.23, p = 0.007; CT vs. CC: OR = 1.20, 95% CI: 1.04–1.39, p = 0.015) are associated with increased risk of RA. Moreover, rs11203366 (G vs. A: OR = 1.46, 95% CI = 1.19–1.78, p = 0.0002, GG vs. AG + AA: OR = 1.42, 95% CI = 1.01–2.01, p = 0.043; GG + AG vs. AA: OR = 2.03, 95% CI = 1.45–2.86, p = 0.00004; GG vs. AA: OR = 2.29, 95% CI = 1.49–3.51, p = 0.0002; AG vs. AA: OR = 1.93, 95% CI = 1.35–2.76, p = 0.0003) and rs11203367 (T vs. C: OR = 1.50, 95% CI = 1.23–1.83, p = 0.00007; TT vs. CT + CC: OR = 1.56, 95% CI = 1.12–2.18, p = 0.009; TT + CT vs. CC: OR = 2.02, 95% CI = 1.43–2.84, p = 0.00007, TT vs. CC: OR = 2.43, 95% CI = 1.59–3.71, p = 0.0004; CT vs. CC: OR = 1.86, 95% CI = 1.30–2.68, p = 0.0007) had an impact in the Latino population. Bioinformatics tools showed the effect of these polymorphisms on gene function. These findings suggest that rs11203366, rs11203367, rs874881 and rs1748033 polymorphisms may be genetic risk factors for RA. Moreover, differences between populations suggest that ethnicity may play an important role in the effect of these polymorphisms on RA risk.
- 9 November 2024
- Published by Wiley in International Journal of Immunogenetics
- Vol. 52 (1) , 1-23
Association of PADI4 Gene Polymorphisms With Susceptibility to Rheumatoid Arthritis: Evidence From 24 Case–Control Studies
This study aims to investigate the association of rs11203366, rs11203367, rs874881, rs2240340 and rs1748033 polymorphisms of protein‐arginine deiminase type 4 (PADI4) gene with the risk of rheumatoid arthritis (RA) through a meta‐analysis that was followed with a bioinformatics approach. The data were collected from reputable articles and underwent quantitative analysis, followed by in silico analysis using some bioinformatics tools. The results showed that rs874881 polymorphism in Latino (G vs. C: OR = 1.35, 95% CI = 1.11–1.65, p = 0.003; GG + CG vs. CC: OR = 2.02, 95% CI = 1.41–2.89, p = 0.0001; CG vs. CC + GG: OR = 1.38, 95% CI = 1.04–1.83, p = 0.027; GG vs. CC: OR = 2.09, 95% CI = 1.35–3.23, p = 0.001; CG vs. CC: OR = 1.98, 95% CI = 1.36–2.87, p = 0.00033) and rs1748033 in Caucasian population (T vs. C: OR = 1.25, 95% CI = 1.07–1.45, p = 0.005; TT vs. CT + CC: OR = 1.34, 95% CI = 1.09–1.64, p = 0.005, TT + CT vs. CC: OR = 1.26, 95% CI = 1.09–1.44, p = 0.001; TT vs. CC: OR = 1.59, 95% CI = 1.13–2.23, p = 0.007; CT vs. CC: OR = 1.20, 95% CI: 1.04–1.39, p = 0.015) are associated with increased risk of RA. Moreover, rs11203366 (G vs. A: OR = 1.46, 95% CI = 1.19–1.78, p = 0.0002, GG vs. AG + AA: OR = 1.42, 95% CI = 1.01–2.01, p = 0.043; GG + AG vs. AA: OR = 2.03, 95% CI = 1.45–2.86, p = 0.00004; GG vs. AA: OR = 2.29, 95% CI = 1.49–3.51, p = 0.0002; AG vs. AA: OR = 1.93, 95% CI = 1.35–2.76, p = 0.0003) and rs11203367 (T vs. C: OR = 1.50, 95% CI = 1.23–1.83, p = 0.00007; TT vs. CT + CC: OR = 1.56, 95% CI = 1.12–2.18, p = 0.009; TT + CT vs. CC: OR = 2.02, 95% CI = 1.43–2.84, p = 0.00007, TT vs. CC: OR = 2.43, 95% CI = 1.59–3.71, p = 0.0004; CT vs. CC: OR = 1.86, 95% CI = 1.30–2.68, p = 0.0007) had an impact in the Latino population. Bioinformatics tools showed the effect of these polymorphisms on gene function. These findings suggest that rs11203366, rs11203367, rs874881 and rs1748033 polymorphisms may be genetic risk factors for RA. Moreover, differences between populations suggest that ethnicity may play an important role in the effect of these polymorphisms on RA risk.
- 14 August 2024
- Published by Springer Nature in Biochemical Genetics
- Vol. 63 (5) , 3773-3795
Association of Functional Genetic Variations in Uric Acid Transporters with the Risk of Idiopathic Male Infertility: A Genetic Association Study and Bioinformatic Analysis
Uric acid plays an important role in sustaining and improving sperm morphology, viability, and motility. It is known that SLC2A9 and ABCG2 protein are the main urate transporter and genetic variations in these genes could be associated with the levels of serum uric acid. This study aimed to investigate the association between single-nucleotide polymorphisms (SNPs) SLC2A9-rs16890979, SLC2A9-rs3733591, ABCG2-rs2231142, and ABCG2-rs2231137 with male infertility. Additionally, the correlation of these SNPs with the uric acid level in seminal plasma of infertile men was examined. Subsequently, an in silico analysis was performed. In a case–control study, 193 infertile and 154 healthy controls were recruited. After semen sample collection, the uric acid level of seminal plasma was measured by a commercial kit. After genomic DNA extraction from sperm samples, SNPs genotyping was performed by PCR–RFLP method. Lastly, the effects of SNPs on the SLC2A9 and ABCG2 gene function were evaluated by bioinformatics tools. The genetic association study revealed that there are significant associations between rs16890979, rs3733591, rs2231142, and rs2231137 genetic variations and increased risk of male infertility. Also, these variations were associated with oligozoospermia and teratozoospermia, and sometimes with asthenozoospermia. Also, we found that four studied SNPs could be associated with a decreased level of uric acid of seminal plasma in teratozoospermia and asthenozoospermia. Bioinformatic analysis revealed that the mentioned polymorphisms could affect molecular aspects of SLC2A9 and ABCG2 genes. In this preliminary study, the rs16890979, rs3733591, rs2231142, and rs2231137 genetic variations could be considered as genetic risk factors for male infertility by interfering with the uric acid level of seminal plasma.
- 14 August 2024
- Published by Springer Nature in Biochemical Genetics
- Vol. 63 (5) , 3773-3795
Association of Functional Genetic Variations in Uric Acid Transporters with the Risk of Idiopathic Male Infertility: A Genetic Association Study and Bioinformatic Analysis
Uric acid plays an important role in sustaining and improving sperm morphology, viability, and motility. It is known that SLC2A9 and ABCG2 protein are the main urate transporter and genetic variations in these genes could be associated with the levels of serum uric acid. This study aimed to investigate the association between single-nucleotide polymorphisms (SNPs) SLC2A9-rs16890979, SLC2A9-rs3733591, ABCG2-rs2231142, and ABCG2-rs2231137 with male infertility. Additionally, the correlation of these SNPs with the uric acid level in seminal plasma of infertile men was examined. Subsequently, an in silico analysis was performed. In a case–control study, 193 infertile and 154 healthy controls were recruited. After semen sample collection, the uric acid level of seminal plasma was measured by a commercial kit. After genomic DNA extraction from sperm samples, SNPs genotyping was performed by PCR–RFLP method. Lastly, the effects of SNPs on the SLC2A9 and ABCG2 gene function were evaluated by bioinformatics tools. The genetic association study revealed that there are significant associations between rs16890979, rs3733591, rs2231142, and rs2231137 genetic variations and increased risk of male infertility. Also, these variations were associated with oligozoospermia and teratozoospermia, and sometimes with asthenozoospermia. Also, we found that four studied SNPs could be associated with a decreased level of uric acid of seminal plasma in teratozoospermia and asthenozoospermia. Bioinformatic analysis revealed that the mentioned polymorphisms could affect molecular aspects of SLC2A9 and ABCG2 genes. In this preliminary study, the rs16890979, rs3733591, rs2231142, and rs2231137 genetic variations could be considered as genetic risk factors for male infertility by interfering with the uric acid level of seminal plasma.